CoronaCentral
Dashboard
Trending
Epidemiology
Forecasting & Modelling
Infection Reports
Transmission
Contact Tracing
Prevalence
Prevention
Surveillance
Clinical
Clinical Reports
Risk Factors
Long Haul
Pediatrics
Medical Specialties
Recommendations
Imaging
Diagnostics
Healthcare Workers
Biology
Molecular Biology
Immunology
Model Systems & Tools
Non-human
Treatment
Therapeutics
Drug Targets
Vaccines
Clinical Trials
Medical Devices
Psychology
Policy
Health Policy
Communication
Inequality
Education
Other Articles
Reviews
Comments & Editorials
CDC Weekly Reports
Book Chapters
News
Non-medical
Retractions
Misinformation
FAQs
Feedback
Select virus of interest
lopinavir [Drug]
Wikidata:
Q422585
Published and Preprint Papers
Filter
Categories
Title
Altmetric
Clinical Reports
,
Long Haul
6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.
Clinical Trials
,
Therapeutics
Repurposed antiviral drugs for COVID-19; interim WHO SOLIDARITY trial results
Clinical Trials
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study.
Clinical Trials
,
Therapeutics
Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial.
Clinical Trials
,
Therapeutics
Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.
Risk Factors
,
Therapeutics
The association of treatment with hydroxychloroquine and hospital mortality in COVID-19 patients.
News
,
Therapeutics
Race to find COVID-19 treatments accelerates.
Therapeutics
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV.
Clinical Trials
,
Therapeutics
Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study.
Therapeutics
Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings.
10
15
20
25
30